Thank you. Is there any way to get instant notifications like we do with say VOX
Now we are on Nasdaq where is market sensitive information posted by the BOD. Are RNS's only for the London Stock Exchange where we no longer exist, if so what is the Nasdaq equivalent?
Can anyone explain why rule 9 has never applied here with GC owning more than 30% of the company for some time?
At the moment, and please correct me if I am wrong, all we have under the JV is an option agreement to acquire 75% at auction price. Now the JV projects potential has become more evident per the RNS then now is the time to acquire some or all of the 9 mines. The cost to acquire could be greater than the $15 m cash they currently have. This is what I think the placing proceeds will be used for which will then mean EUA can then sell on or if they wish mine some or part of it themselves.
I think the next RNS will be confirmation of acquiring some or all of the licences which will result in EUA sitting on in excess of 100m oz pgm
Nasdaq closed yesterday at an equivalent price of 58p. Surely all that matters from now on (unless you are looking to buy or sell) is the price on Nasdaq as ultimately that's where the shares that we hold will be traded.
Interesting to see how Nasdaq reacts today when it opens. I hope it likes it
Best interview I have seen for a while. Patience is the key here. Success in just one of the areas and it will make TILS a billion dollar company.
Hi Rockz. I hope you are correct. I have a large holding here and am well under water but believe in what they are doing and am happy to sit it out and wait. I view tils as a long term hold - unless they are bought out of course
Atb
I have also put a call in to the company only to be directed to voicemail. I left a message for Hannah asking for a call back. Chances of getting one??
Jes - the price can be determined by how much our potential buyers are prepared to pay for what we own already. You don’t buy something for £1 and sell it for £1. By incorporating both assets do they suddenly become worth more than their individual values. Does it add marriage value. If not then we mine it ourself. Just my thoughts. I’m heavily invested here with so want the best outcome just don’t understand why some people suddenly think we all of a sudden have an extra £100 m oz to sell without having to buy it first.
But don’t we have to buy these additional resources at market value. Are we not buying for £1 to have something worth £1 - unless we mine it ourselves. We are not getting it for nothing or the $.5m that has been already paid
Per the RNS
The total of the Initial Consideration and the Earnout (if applicable) is capped at 75% of the value set under the relevant Russian law if the Additional Assets had initially been auctioned by the Russian state instead of being acquired by Rosgeo.
Just throwing this out for comment. How much funding will be required to bring Accustem through to market over a two/three year period. If Accustem is launched with only £1m this won’t be enough to progress it forward at the scale required. If the initial share price is low will a placing/dilution raise sufficient funds? Another option and could it be the reason for the current delay is that is GC looking at a joint venture with a major player who could be one the the NDA’s previously referred to? For a stake in the company they could provide the funding to bring this product (40% better than the market leader) to market. Take a look at GGP and their JV with Newcrest. Without that joint venture, GGP would not be where they are today. As someone said on the GGP forum, isn’t it better to have a % share of something rather than 100% of nothing. Could be way of the mark here but trying to work out why notification of the listing is being delayed.
And hence the reason for my initial post. If it is too cheap does it leave it open to a takeover?
I don’t know if they can price it higher. I’m hoping there are far more knowledgeable people on here than me that can answer that question. Would I like a sale being negotiated now at its estimated value of 10% of exact sciences or would I hold and hope that they bring this far superior product to market with an eventual mcap of £2.8b or more. I would gladly hold. What I don’t know is what the likely cost/dilution would be to bring Accustem up to a par with its rival with a ready market.
Thanks for your reply and I hope you are correct but if launched at such a low price just how high would it push the sp. Yes the sp of Gms rose to circa 14p and fortunately I got out at that level as Seafox have now taken control of the board and the share price is down to 6.5p. They have not taken their holding to 30% yet as to do so my understanding is that would have to pay 14p for the remaining shares but once 6 months have lapsed from the date 14p was paid then they are no longer required to pay that level of value. From a launch of say 30p to the £1.43 per share as initially muted that was the value of Stem would mean the sp having to 5 bag.
This is my first post on any share forum. I have a wide range of investments in about 20 companies but have preferred to sit on the sidelines and read and learn from those far more knowledgeable than me. This so far has worked and am sat with a portfolio over 10% up even when being heavily underwater with tils (excluding the value of Accustem).
When talk first emerged of Stem being split off people talked about a value iro £280m based on approx 10% of Exact Sciences deal at £2.8 billion. At £280m it would equate to a share value of £1.43 on the assumption Stem has the same number of shares as tils (195m). Stem has been shown in tests to be 40% better than the market leader but does not have a ready market unlike it’s competitor. If it was at the same stage then at £2.8b it would equate to a share value of £14.30. Obviously capital would need to be raised to bring Stem up to a par with its competitor but long term I can see a value for Accustem well in excess of 10% of the value of its competitor. Maybe one day on a par with it or higher.
My main reason for posting is this. If Accustem is launched at 30p or thereabouts as has been mentioned earlier would this not leave it open for a hostile takeover? One of my holdings GMS is in a similar scenario where Sea Fox have amassed 29% of the shares knowing that once they cross 30% they will have to buy the remaining shares at the highest share price within the last 6 months. Let’s say for example the share price is 30p it will place an Mcap on Accustem of 195m x 30p = £58.5m, a value equivalent to 2% or thereabouts of the Exact Sciences deal. Surely if you knew your competitor was looking to develop then market a product 40% better than what you had would you not look to take them out at such a low value. Consequently how can this be prevented from happening. Is there any justification for a higher share price at launch? I may be totally off the mark here but would hope that those more knowledgeable than me can perhaps provide some input.